Silica nanoparticles trigger hepatic lipid-metabolism disorder in vivo and in vitro

References

• TangLChengJNonporous silica nanoparticles for nanomedicine applicationNano Today20138329031223997809
   PubMed Web of Science ®Google Scholar
• XuRZhangGMaiJAn injectable nanoparticle generator enhances delivery of cancer therapeuticsNat Biotechnol201634441441826974511
   PubMed Web of Science ®Google Scholar
• World Health OrganizationWHO Guidelines on Protecting Workers from Potential Risks of Manufactured NanomaterialsGenevaWorld Health Organization2017 Available from: http://www.who.int/occupational_health/publications/manufactured-nanomaterials/en/Accessed October 29, 2018
   Google Scholar
• NelAEParakWJChanWCWhere are we heading in nanotechnology environmental health and safety and materials characterization?ACS Nano2015965627563026100220
   PubMed Web of Science ®Google Scholar
• BenezraMPenate-MedinaOZanzonicoPBMultimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanomaJ Clin Invest201112172768278021670497
   PubMed Web of Science ®Google Scholar
• MurugadossSLisonDGodderisLToxicology of silica nanoparticles: an updateArch Toxicol20179192967301028573455
   PubMed Web of Science ®Google Scholar
• KumarRRoyIOhulchanskkyTYIn vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticlesACS Nano20104269970820088598
   PubMed Web of Science ®Google Scholar
• SmuldersSKetkar-AtreALuytsKBody distribution of SiO2-Fe3O4 core-shell nanoparticles after intravenous injection and intratracheal instillationNanotoxicology201610556757426525175
   PubMed Web of Science ®Google Scholar
• NaganoTHigashisakaKKuniedaALiver-specific microRNAs as biomarkers of nanomaterial-induced liver damageNanotechnology2013244040510224029385
   PubMed Web of Science ®Google Scholar
• ChenQXueYSunJKupffer cell-mediated hepatic injury induced by silica nanoparticles in vitro and in vivoInt J Nanomedicine201381129114023515466
   PubMed Web of Science ®Google Scholar
• YuYLiYWangWAcute toxicity of amorphous silica nanoparticles in intravenously exposed ICR micePLoS One201384e6134623593469
   PubMed Web of Science ®Google Scholar
• YuYDuanJLiYSilica nanoparticles induce liver fibrosis via TGF-β1/Smad3 pathway in ICR miceInt J Nanomedicine2017126045605728860765
   PubMed Web of Science ®Google Scholar
• ItemFWueestSLemosVFas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial functionNat Commun20178148028883393
   PubMedGoogle Scholar
• WilleitPSkroblinPKiechlSFernández-HernandoCMayrMLiver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?Eur Heart J201637433260326627099265
   PubMed Web of Science ®Google Scholar
• ZhouHLiuRER stress and hepatic lipid metabolismFront Genet2014511224847353
   PubMed Web of Science ®Google Scholar
• LiYYuYDuanJThe internalization, distribution, and ultra-structure damage of silica nanoparticles in human hepatic L-02 cellsPart Part Syst Charact2016339664674
   Web of Science ®Google Scholar
• HickenCELinboTLBaldwinDHSublethal exposure to crude oil during embryonic development alters cardiac morphology and reduces aerobic capacity in adult fishProc Natl Acad Sci U S A2011108177086709021482755
   PubMed Web of Science ®Google Scholar
• Marín-JuezRJong-RaadsenSYangSSpainkHPHyperinsulinemia induces insulin resistance and immune suppression via Ptpn6/Shp1 in zebrafishJ Endocrinol2014222222924124904114
   PubMed Web of Science ®Google Scholar
• DuanJYuYLiYYuYSunZCardiovascular toxicity evaluation of silica nanoparticles in endothelial cells and zebrafish modelBiomaterials201334235853586223663927
   PubMed Web of Science ®Google Scholar
• DuanJYuYLiYLow-dose exposure of silica nanoparticles induces cardiac dysfunction via neutrophil-mediated inflammation and cardiac contraction in zebrafish embryosNanotoxicology201610557558526551753
   PubMed Web of Science ®Google Scholar
• ZhouJXuYQGuoSYLiCQYqXCqLRapid analysis of hypolipidemic drugs in a live zebrafish assayJ Pharmacol Toxicol Methods201572475225497901
   PubMed Web of Science ®Google Scholar
• HuHLiQJiangLZouYDuanJSunZGenome-wide transcriptional analysis of silica nanoparticle-induced toxicity in zebrafish embryosToxicol Res201652609620
   Web of Science ®Google Scholar
• MebertAMBagloleCJDesimoneMFMaysingerDNanoengineered silica: properties, applications and toxicityFood Chem Toxicol2017109Pt 175377028578101
   PubMedGoogle Scholar
• VesterdalLKDanielsenPHFolkmannJKAccumulation of lipids and oxidatively damaged DNA in hepatocytes exposed to particlesToxicol Appl Pharmacol2014274235036024121055
   PubMed Web of Science ®Google Scholar
• JiaJLiFZhouHOral exposure to silver nanoparticles or silver Ions may aggravate fatty liver disease in overweight miceEnviron Sci Technol201751169334934328723108
   PubMed Web of Science ®Google Scholar
• OróDYudinaTFernández-VaroGCerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosisJ Hepatol201664369169826519601
   PubMed Web of Science ®Google Scholar
• Lemaire-EwingSLagrostLNéelDLipid rafts: a signalling platform linking lipoprotein metabolism to atherogenesisAtherosclerosis2012221230331022071358
   PubMed Web of Science ®Google Scholar
• GongZTasEYakarSMuzumdarRHepatic lipid metabolism and non-alcoholic fatty liver disease in agingMol Cell Endocrinol201745511513028017785
   PubMed Web of Science ®Google Scholar
• SáinzNBarrenetxeJMoreno-AliagaMJMartínezJALeptin resistance and diet-induced obesity: central and peripheral actions of leptinMetabolism2015641354625497342
   PubMed Web of Science ®Google Scholar
• ArsenaultRJKogutMHHeHCombined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligandsCell Signal201325112246225423876795
   PubMed Web of Science ®Google Scholar
• TakeuchiOAkiraSPattern recognition receptors and inflammationCell2010140680582020303872
   PubMed Web of Science ®Google Scholar
• FresnoMAlvarezRCuestaNReceptors T-LikeInflammation, metabolism and obesityArch Physiol Biochem201111715116421599616
   PubMedGoogle Scholar
• MckernanDPGasznerGQuigleyEMCryanJFDinanTGAltered peripheral toll-like receptor responses in the irritable bowel syndromeAliment Pharmacol Ther20113391045105221453321
   PubMed Web of Science ®Google Scholar
• ClarkeGMcKernanDPGasznerGQuigleyEMCryanJFDinanTGA distinct profile of tryptophan metabolism along the kynurenine pathway downstream of toll-like receptor activation in irritable bowel syndromeFront Pharmacol201239022661947
   PubMed Web of Science ®Google Scholar
• KönnerACBrüningJCToll-like receptors: linking inflammation to metabolismTrends Endocrinol Metab2011221162320888253
   PubMed Web of Science ®Google Scholar
• PekkalaSMunukkaEKongLToll-like receptor 5 in obesity: the role of gut microbiota and adipose tissue inflammationObesity201523358159025611816
   PubMed Web of Science ®Google Scholar
• MunukkaEWiklundPPartanenTAdipocytes as a link between gut microbiota-derived flagellin and hepatocyte fat accumulationPLoS One2016114e015278627035341
   PubMed Web of Science ®Google Scholar
• HusseySELumHAlvarezAA sustained increase in plasma NEFA upregulates the toll-like receptor network in human muscleDiabetologia201457358259124337154
   PubMed Web of Science ®Google Scholar